The Enterprise Value as of June 2025 (TTM) for Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) is 9.41B

According to Vcanbio Cell & Gene Engineering Corp., Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 9.41B. This represents a change of 19.63% compared to the average of 7.87B of the last 4 quarters.

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) Historical Enterprise Value (quarterly & annually)

How has 600645.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Vcanbio Cell & Gene Engineering Corp., Ltd over the last ten years is 9.86B. The current 9.41B Enterprise Value has changed 9.44% with respect to the historical average. Over the past ten years (40 quarters), 600645.SS's Enterprise Value was at its highest in in the September 2015 quarter at 30.35B. The Enterprise Value was at its lowest in in the March 2024 quarter at 6.01B.

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vcanbio Cell & Gene Engineering Corp., Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) Average Enterprise Value

How has 600645.SS Enterprise Value performed in the past?

The current Enterprise Value of Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) Enterprise Value vs. Peers

How is 600645.SS’s Enterprise Value compared to its peers?

Vcanbio Cell & Gene Engineering Corp., Ltd’s Enterprise Value is less than Zhejiang Daily Digital Culture Group Co.,Ltd. (16.43B), greater than China Reform Culture Holdings Co., Ltd. (2.93B), greater than Shanghai Chlor-Alkali Chemical Co., Ltd. (7.33B), greater than Harbin Pharmaceutical Group Co., Ltd. (7.98B), greater than Aurora Optoelectronics Co.,Ltd. (7.11B),

Build a custom stock screener for Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vcanbio Cell & Gene Engineering Corp., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vcanbio Cell & Gene Engineering Corp., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.